FIELD: medicine.
SUBSTANCE: hepatotropic preparation Hepaguard Active is administered in a dose of 1 capsule 3 times a day at mealtimes for 28-30 days.
EFFECT: method enables recovering and maintaining the optimum health of intestinal microbiocenosis by ensuring a possibility to have an effect on its various links.
3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2400235C1 |
METHOD OF TREATING PATIENTS WITH HEPATIC CIRRHOSIS | 2012 |
|
RU2509566C1 |
METHOD OF TREATING INTESTINAL DYSBACTERIOSIS | 2015 |
|
RU2602696C1 |
METHOD OF CONTROLLING EFFECTIVENESS OF CORRECTING INTESTINAL MICROBIOCENOSIS DISTURBANCES | 2009 |
|
RU2410031C1 |
METHOD OF TREATING CHRONIC INFLAMMATORY PELVIC DISEASES | 2010 |
|
RU2445988C1 |
METHOD FOR PROBIOTIC CORRECTION OF POSTINTOXIFICATION PSYCHOSIS IN PATIENTS SUFFERING ALCOHOL DEPENDENCE SYNDROME | 2011 |
|
RU2480226C1 |
METHOD OF ESTIMATING CONDITION COLONISATION RESISTANCE OF HUMAN BIOTOPE MICROBIOCENOSIS (VERSIONS) | 2008 |
|
RU2381504C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC LIVER DISEASES IN STAGE OF LATENCY AND DEGREE I MANIFESTED STAGE OF HEPATIC ENCEPHALOPATHY | 2011 |
|
RU2462251C1 |
DIAGNOSTIC TECHNIQUES FOR VARIOUS FORMS OF CHRONIC TONSILLITIS | 2009 |
|
RU2429477C2 |
METHOD OF DRUG-FREE THERAPY OF PATIENTS WITH CHRONIC GASTROINTESTINAL DISEASES | 2012 |
|
RU2489157C1 |
Authors
Dates
2015-12-20—Published
2014-09-23—Filed